Li-Fraumeni综合征患者结直肠肿瘤发生率研究
该回顾性队列研究分析了663例Li-Fraumeni综合征(LFS)患者的结直肠肿瘤发生率,其中206例成人接受了311次监测性结肠镜检查。结果显示成人LFS患者的总肿瘤检出率为37%、腺瘤检出率27%、锯齿状病变检出率9.3%,且45-75岁及男性检出率更高。研究支持当前对LFS患者较平均风险人群更早、更频繁进行结肠镜监测的建议。
要点
- LFS成人总肿瘤检出率37%,腺瘤检出率27%,锯齿状病变检出率9.3%。
- 45-75岁成人各项检出率均高于25-45岁组。
- 男性总肿瘤检出率、腺瘤检出率及进展期腺瘤检出率均显著高于女性。
核心结论
- LFS患者腺瘤检出率与平均风险成人相当,但锯齿状病变检出率更高,且与TP53致病性胚系变异亚型无关。
- 数据支持当前建议LFS患者较平均风险指南更早、更频繁进行结肠镜监测,适用于所有LFS表型。
研究设计与样本
- 回顾性队列研究,纳入663例LFS患者(成人及儿童),其中206例成人接受了2019年1月至2024年8月期间的311次监测性结肠镜检查。
- 按年龄、性别和TP53致病性胚系变异亚型分层分析结直肠肿瘤检出率。
主要发现
- 663例成人中结直肠癌报告率为4.5%,124例儿童患者中为0.8%。
- 206例接受结肠镜的成人中,总肿瘤检出率37%、腺瘤检出率27%、锯齿状病变检出率9.3%、进展期癌前息肉检出率4.5%、结直肠癌检出率0.64%。
- 功能缺失型与亚效型TP53致病性胚系变异之间的检出率相似。
- 45-75岁成人的总肿瘤检出率、腺瘤检出率、进展期腺瘤检出率、锯齿状病变检出率及结直肠癌检出率均高于25-45岁成人。
- 男性总肿瘤检出率53.7% vs 30.7%(P=0.0004),腺瘤检出率41.2% vs 22.1%(P=0.0013),进展期腺瘤检出率7.5% vs 1.3%(P=0.0105)。
关键数值与推荐
- 总肿瘤检出率37%,腺瘤检出率27%,锯齿状病变检出率9.3%,进展期癌前息肉检出率4.5%,结直肠癌检出率0.64%(206例接受结肠镜的LFS成人)。
- 男性总肿瘤检出率53.7% vs 女性30.7%(P=0.0004);腺瘤检出率41.2% vs 22.1%(P=0.0013);进展期腺瘤检出率7.5% vs 1.3%(P=0.0105)。
临床怎么用
- 对LFS患者应遵循较平均风险指南更早、更频繁的结肠镜监测建议,不受TP53致病性胚系变异亚型影响。
- 临床监测中需关注男性LFS患者及45-75岁年龄段的更高肿瘤检出风险。
局限性
- 回顾性队列研究设计可能引入选择偏倚和信息偏倚。
- 结肠镜监测数据仅来自206例成人中的311次检查,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Individuals with Li-Fraumeni syndrome (LFS), a cancer predisposition syndrome caused by TP53 pathogenic germline variants (PGV), have an increased risk of colorectal cancer (CRC). However, limited data exist on colonoscopy metrics, including total neoplasia detection rates, in patients with LFS. METHODS: We conducted a retrospective cohort study of colorectal neoplasia incidence and characteristics in 663 individuals with LFS. We determined total neoplasia detection rate, adenoma detection rate (ADR), advanced ADR, serrated lesion detection rate (SDR), and CRC detection rate, stratified by age, sex, and PGV subtype, in 311 surveillance colonoscopies from 206 adults performed January 2019 to August 2024. RESULTS: CRC was reported in 4.5% of 663 adults and 0.8% of 124 pediatric patients with LFS. Among 206 adults undergoing colonoscopy, total neoplasia detection rate, ADR, SDR, advanced precancerous polyp detection rate, and CRC detection rate were 37%, 27%, 9.3%, 4.5%, and 0.64%, respectively. Detection rates were similar between loss of function and hypomorphic PGVs. Adults aged 45-75 had higher total neoplasia detection rate, ADR, advanced ADR, SDR, and CRC detection rate than those aged 25-45. Male sex was associated with increased total neoplasia detection rate (53.7% vs 30.7%, P = 0.0004), ADR (41.2% vs 22.1%, P = 0.0013), and advanced ADR (7.5% vs 1.3%, P = 0.0105). DISCUSSION: Patients with LFS have comparable ADR and higher SDR with average-risk adults despite earlier, more frequent surveillance, irrespective of TP53 PGV subtype. Our data support current recommendations for earlier and more frequent colonoscopy surveillance than average-risk guidelines, across LFS phenotypes.
引用
- Spiegel SR, Orr C, Edgar NU, et al. Colorectal Neoplasia Rates in Li-Fraumeni Syndrome. Am J Gastroenterol. 2026. PMID: 41738599. doi:10.14309/ajg.0000000000003976
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。